Biosynthesis · Beauty, Naturally
Echo Orea Invites You to the 30th CBE China Beauty Expo
As efficacy-focused skincare becomes increasingly competitive, where will the next growth opportunity come from?
As the medical-aesthetics industry faces a traffic bottleneck, how can brands build repeat purchases?
As product life cycles continue to shorten, where can truly exceptional products be found?
Echo Orea’s answer is cosmetic–medical device integration with full-process management.
Built on a synthetic biology technology platform, Echo Orea connects three key scenarios—professional medical aesthetics, at-home aesthetic care, and daily skincare. Its pharmaceutical-grade R&D capabilities create a compliant, efficient, and sustainable growth path for partners.
From May 12 to 14 at Booth E5D32, Shanghai New International Expo Centre, we will present advanced ingredients, major new products, and dedicated partnership programs. Join us in exploring the next blue ocean of efficacy-focused skincare.
A New Blue Ocean for Cosmetic–Medical Device Integration
Traditional beauty and skincare channels are fragmented. Echo Orea creates a seamless connection from professional medical aesthetics to at-home maintenance:
Medical-Aesthetic Scenario: A Class II medical-device product portfolio addressing immediate post-procedure care, barrier rebuilding, and other essential needs.
At-Home Aesthetic Scenario: Integrated medical-device and cosmetic solutions that extend maintenance after professional treatments.
Daily Skincare Scenario: Efficacy-focused cosmetic products that bring medical-aesthetic-grade ingredients into everyday routines.
Preview of the New Product Portfolio
Efficacy, application scenarios, and hero-product strategy are all represented. In addition to the existing flagship lineup, major new products will make their debut at the show:
Advanced New Ingredients
Recombinant functional-protein products including PDRN and conotoxin peptides will launch together, expanding the boundaries of anti-aging and repair efficacy through synthetic biology.
Multi-Channel and Policy Advantages
Omnichannel Fit: Medical-aesthetic institutions, dermatology clinics, professional beauty salons, maternal and infant channels, e-commerce livestreaming, and community group buying—integrated cosmetic and medical-device solutions support both order value and repeat purchases.
One-Stop ODM/OEM Services: Full-chain customization from formulation R&D and sample preparation to Class II medical-device registration.
Exhibition-Exclusive Programs: Visit Booth E5D32 for details.
Exhibition Information
Opening Dates:
May 12–14, 2026
Booth: E5D32
Venue: Shanghai New International Expo Centre, 2345 Longyang Road, Pudong New Area, Shanghai
How to Attend
Advance registration is required. Scan the QR code below to reserve your place and discover more “authentic collagen” anti-aging and repair solutions at the venue.
ABOUT US
Biosynthesis · Beauty, Naturally
Yaohai Novagen is a biotechnology company incubated by Yaohai Biopharmaceutical, a national-level specialized and innovative enterprise, and is dedicated to providing science-based solutions for problem skin. Building on its parent company’s expertise in microbial expression systems and synthetic biology, the company has established an integrated R&D, manufacturing, and sales platform. Its brand Echo Orea provides problem skin with effective solutions rooted in science and supported by professional validation, with a focus on the development and commercialization of bioactive ingredients such as recombinant collagen. Pharmaceutical-grade rigor is applied throughout the skincare development process, with an emphasis on evidence-based efficacy rather than concept-driven formulation. R&D innovation, research-manufacturing, and user research bases in Beijing, Taizhou, and Nanjing create a complete loop from technical insight to user needs, helping more people achieve confident, healthy, and natural beauty. By integrating pharmaceutical expertise, advanced ingredient technology, and professional pharmacy channels, Echo Orea has also established a distinctive model of co-creation between medical and research professionals.
